A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC

Clinical trial NCT00743938 · COMPLETED

Trial details

NCT number: NCT00743938
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2009-03-01
Primary completion: 2010-08-01
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.